ANTIKÖRPERFORMULIERUNG

European patent · EP3072906 · In force

Register entry

Publication number
EP3072906
Application number
EP16162699
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 9, 2009
Published
Sep 28, 2016
Granted
Sep 8, 2021
Protection ends at the latest
Dec 8, 2029
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/24 (2006.01)
A61K 39/395 (2006.01)
Priority
EP 08170884 10.12.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Jul 20, 2022

    Change

    Published in Swissreg on 20.07.2022

  6. Sep 8, 2021

    Granted

    Published in Swissreg on 08.09.2021

Parties

Holder

Novartis AG

NOVARTIS AG

Lichtstrasse 35, 4056 Basel

Inventor

WALLNY, Hans-Joachim

CH-4002 Basel

MOMM, Joachim

CH-4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.